Health Policy Advocacy: Moving Mountains from Reports to Real Change
Anna Dé, Founder and Senior Health Policy Advisor at Anna Dé Healthcare Policy Consultancy, shared a post on LinkedIn:
“It’s the elephant in the room.
Across health policy, patient advocacy and communications – we all know the pattern:
- Beautiful reports.
- Slick campaigns.
- But too often, calls to action are vague, performative or overloaded.
This means:
- No policy shift.
- No budget change.
- No real impact.
We keep producing materials that look good…but go nowhere.
And until now, no one was really talking about it.
So we did something about it.
Michael George and I created the Moving Mountains Framework – a practical, human-centred approach to health policy and advocacy that actually creates change.
- Momentum
- Community
- Pressure
That’s what moves systems – not a lonely PDF….
In this new piece, we break down the 5 steps behind the framework and how to move from publishing reports… to transforming lives.
Read the article here.
How many of us have worked on reports that looked great – but didn’t lead to change? Why does it keep happening?
Drop an elephant in the comments if this resonates.
Time to name it and move it.
Let’s stop collecting dust and start moving mountains.
— Anna Dé and Michael George”
Read more on Hemostasis Today.
-
Nov 4, 2025, 09:26Courtney Lawrence: One of Our Most Popular American Red Cross SUCCESS Talks is Just Around the Corner!
-
Nov 4, 2025, 09:21New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
-
Nov 4, 2025, 09:20Yazan Abou Ismail to Present Insights on AI Models in TTP at 67th ASH Annual Meeting
-
Nov 4, 2025, 09:17David Calvet Canut on Takeda's HyHub: A Shift Toward Patient-Centered Biologics
-
Nov 4, 2025, 09:16Samantha Nelson Encourages You to Share Your Experience on World Thrombosis Day
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!